Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis

[Image: see text] Multiple effects on cancer cells are exerted by the peroxisome proliferator-activated receptor γ (PPAR-γ). Recent studies have shown that rosiglitazone, a synthetic PPAR-γ ligand, inhibits the growth of cells. This research was designed to assess the impact of rosiglitazone on diet...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yanqiao, Sreeharsha, Nagaraja, Sharma, Sanjay, Mishra, Anurag, Singh, Avinash Kumar, Gubbiyappa, Shiva Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081392/
https://www.ncbi.nlm.nih.gov/pubmed/32201822
http://dx.doi.org/10.1021/acsomega.9b04357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081392/
https://www.ncbi.nlm.nih.gov/pubmed/32201822
http://dx.doi.org/10.1021/acsomega.9b04357

Ejemplares similares